To be considered you must have-
Prior discontinuation of Orkambi, with at least 1 respiratory sign or symptom considered related to therapy.
Discontinuation of Orkambi therapy must have occurred <8 weeks from the first dose of Orkambi.
FEV1 ≥25% and ≤90% of predicted normal for age, sex, and height.
https://clinicaltrials.gov/ct2/show/NCT03150719?term=661-114&rank=1
Prior discontinuation of Orkambi, with at least 1 respiratory sign or symptom considered related to therapy.
Discontinuation of Orkambi therapy must have occurred <8 weeks from the first dose of Orkambi.
FEV1 ≥25% and ≤90% of predicted normal for age, sex, and height.
https://clinicaltrials.gov/ct2/show/NCT03150719?term=661-114&rank=1